Skip to main content
John Spertus, MD, Cardiology, Kansas City, MO

JohnASpertusMD

Cardiology Kansas City, MO

Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine

Dr. Spertus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Spertus' full profile

Already have an account?

  • Office

    4320 Wornall Rd
    Suite 65
    Kansas City, MO 64111
    Phone+1 816-932-6100
    Fax+1 816-461-6586

Education & Training

  • University of Washington
    University of WashingtonFellowship, Cardiovascular Disease, 1992 - 1996
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1989 - 1992
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1989

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 1996 - 2025
  • WA State Medical License
    WA State Medical License 1989 - 1996
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2006
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Potential Association of the ISCHEMIA Trial with the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease  
    John A Spertus, Manesh R Patel, JAMA Internal Medicine
  • Association of Perceived Stress Levels with Long-Term Mortality in Patients with Peripheral Artery Disease  
    Poghni Peri-Okonny, John A Spertus, JAMA Network Open
  • Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant Centers  
    Jon A Kobashigawa, Steven W Tabak, Wendy Book, John A Spertus, JAMA Cardiology
  • Join now to see all

Lectures

  • Diagnostic Testing in Older Adult Patients with Coronary Artery Disease: Choosing Wisely 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • What Every Cardiologist Should Know: QoL Improvements Following Revascularization for Stable Angina. 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Why We Need to Incorporate Patient Reported Outcomes in Heart Failure Guidelines 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Authored Content

  • Association of Perceived Stress Levels with Long-Term Mortality in Patients with Peripheral Artery DiseaseJune 2020
  • Comparison of Patient-Reported vs Physician-Estimated Angina in Patients Undergoing Elective and Urgent Percutaneous Coronary InterventionJune 2020
  • Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant CentersApril 2020
  • Patient and Practice Characteristics Associated with Sacubitril/Valsartan Use in the United StatesSeptember 2018
  • Sustaining Quality of Life of the Aged: Transplant or Mechanical Support: Baseline Cognitive DysfunctionAugust 2018
  • Join now to see all

Press Mentions

  • UMKC and Saint Luke’s to Lead Nationwide Study on Pregnant People with Heart Disease to Combat Maternal Deaths and Illnesses
    UMKC and Saint Luke’s to Lead Nationwide Study on Pregnant People with Heart Disease to Combat Maternal Deaths and IllnessesSeptember 30th, 2024
  • Saint Luke’s and UMKC to Lead Nationwide Study on Pregnant People with Heart Conditions in Effort to Help Combat Maternal Morbidity, Mortality
    Saint Luke’s and UMKC to Lead Nationwide Study on Pregnant People with Heart Conditions in Effort to Help Combat Maternal Morbidity, MortalitySeptember 30th, 2024
  • Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024
    Insights from the SEQUOIA-HCM Trial and SEQUOIA-HCM CRM Substudy | ESC 2024September 3rd, 2024
  • Join now to see all

Grant Support

  • Cardiovascular Outcomes Research Training ProgramNational Heart, Lung, And Blood Institute2012
  • Transforming PCI Informed Consent Into An Evidence-Based Decision-Making ToolNational Heart, Lung, And Blood Institute2009–2010
  • Investigating Racial Disparities In Outcomes After AMINational Heart, Lung, And Blood Institute2005–2009
  • Risk-Adjustment Of 1-Year Health Status Outcomes In CADAgency For Healthcare Research And Quality2000–2003

Professional Memberships